Watson CEO Claims FTC Pressured Company To Allow Apotex To Market Generic Provigil
This article was originally published in The Pink Sheet Daily
Executive Summary
Watson CEO Paul Bisaro is fighting an FTC subpoena to testify in the commission's investigation of a reverse settlement agreement involving Cephalon's Provigil.